查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1854937

全球心肺设备市场成长、规模和趋势分析（按组件、应用和最终用户划分）—区域展望、竞争策略和细分市场预测（至2034年）

Global Heart-lung Machine Market Growth, Size, Trends Analysis - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 269 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，全球心肺设备市场规模将达到 49.9 亿美元，复合年增长率为 7.15%。

体外循环机，也称为心肺体外迴圈（CPB机），是一种用于在心臟直视手术期间暂时替代心臟和肺功能的装置。该机器将血液从心臟和肺部抽出，进行氧合后再输回体内，因此可以在心臟停止跳动的情况下进行手术。体外循环机主要由帮浦、氧合器以及各种监控和控制系统组成。帮浦负责将血液循环至全身，而氧合器则负责去除血液中的二氧化碳并提供氧气。

阻碍因素：儘管全球心肺设备市场受益于许多有利的成长要素，但也存在一些阻碍其扩张的因素。例如，设备及其维护成本高昂，阻碍了其广泛应用，尤其是在开发中国家。此外，心肺设备的操作和维护需要高水准的专业知识和培训，这可能会限制其在设施和人员有限的小型医疗机构中的使用。

本报告调查了全球心肺设备市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、按各个细分市场、地区/主要国家进行的详细分析、竞争格局以及主要企业的概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动因素、阻碍因素、机会与挑战分析

第五章 市场变数与展望

  • SWOT分析
  • PESTEL 分析
  • 波特五力分析
  • 热图分析

第六章 竞争情势

  • 製造地、销售区域和产品类型的分布
  • 併购、合作、产品发布与协作

7. 全球心肺设备市场（依组件划分）

  • 氧合设备
  • 泵浦
  • 套管
  • 监控系统
  • 热交换单元
  • 血液储备
  • 其他的

8. 全球心肺设备市场（按应用划分）

  • 冠状动脉绕道手术（CABG）
  • 心臟瓣膜手术
  • 心臟移植
  • 肺移植
  • 其他的

9. 全球心肺设备市场（依最终用户划分）

  • 医院
  • 心臟中心
  • 其他的

第十章：全球心肺设备市场

  • 全球心肺设备市场规模及市场份额

第十一章 全球心肺设备市场（按地区划分）

  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亚
    • 其他的
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美国
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他的

第十二章：公司简介

  • Braile BiomA(C)dica
  • ELITE LIFECARE
  • Getinge
  • Hemovent GmbH
  • LivaNova, Inc
  • Medtronic
  • MERA (Senko Medical Instrument Mfg. Co., Ltd)
  • NIPRO
  • Technowood International Pte. Ltd

第十三章 结论

第十四章简称列表

第十五章参考链接

简介目录
Product Code: MEDE2555

Heart lung Machine Market Introduction and Overview

According to SPER Market Research, 'Global Heart-lung Machine Market Size - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Heart-lung Machine Market is predicted to reach 4.99 billion by 2034 with a CAGR of 7.15%.

The heart-lung machine, also referred to as the cardiopulmonary bypass (CPB) machine, is a tool used to temporarily replace the heart and lungs during open heart surgery. By removing blood from the heart and lungs, oxygenating it, and then reintroducing it into the body, it enables surgeons to do surgery on a still heart. A pump, an oxygenator, and other monitoring and control systems make up the machine. As the pump circulates blood throughout the body, the oxygenator removes carbon dioxide and adds oxygen to the blood.

Restraints: Despite the favorable factors propelling the global market for heart-lung machines, certain barriers impede its expansion. For example, the high expense of heart-lung machines and their upkeep prevents them from being widely used, especially in developing nations. The use of these devices in smaller healthcare facilities with fewer resources may be restricted due to the complexity of their operation and maintenance, which calls for specialized training.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Component, By Application, By End-User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Braile BiomA(C)dica, ELITE LIFECARE, Getinge, Hemovent GmbH, LivaNova, Inc, Medtronic, MERA (Senko Medical Instrument Mfg. Co, Ltd), NIPRO, Technowood International Pte Ltd.

Global Heart-lung Machine Market Segmentation:

By Component: Based on the Component, Global Heart-lung Machine Market is segmented as; Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoir, Others.

By Application: Based on the Application, Global Heart-lung Machine Market is segmented as; Coronary Artery Bypass Grafting (CABG), Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others.

By End-User: Based on the End-User, Global Heart-lung Machine Market is segmented as; Hospitals, Cardiac Centers, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1.Introduction

  • 1.1.Scope of the report
  • 1.2.Market segment analysis

2.Research Methodology

  • 2.1.Research data source
    • 2.1.1.Secondary Data
    • 2.1.2.Primary Data
    • 2.1.3.SPERs internal database
    • 2.1.4.Premium insight from KOLs
  • 2.2.Market size estimation
    • 2.2.1.Top-down and Bottom-up approach
  • 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

  • 4.1.Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1.Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges

5.Market variable and outlook

  • 5.1.SWOT Analysis
    • 5.1.1.Strengths
    • 5.1.2.Weaknesses
    • 5.1.3.Opportunities
    • 5.1.4.Threats
  • 5.2.PESTEL Analysis
    • 5.2.1.Political Landscape
    • 5.2.2.Economic Landscape
    • 5.2.3.Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5.Environmental Landscape
    • 5.2.6.Legal Landscape
  • 5.3.PORTERs Five Forces
    • 5.3.1.Bargaining power of suppliers
    • 5.3.2.Bargaining power of buyers
    • 5.3.3.Threat of Substitute
    • 5.3.4.Threat of new entrant
    • 5.3.5.Competitive rivalry
  • 5.4.Heat Map Analysis

6.Competitive Landscape

  • 6.1.Global Heart-lung Machine Market Manufacturing Base Distribution, Sales Area, Interface Type
  • 6.2.Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Heart-lung Machine Market

7.Global Heart-lung Machine Market, By Component 2021-2034 (USD Million)

  • 7.1.Oxygenators
  • 7.2.Pumps
  • 7.3.Cannula
  • 7.4.Monitoring Systems
  • 7.5.Heat Exchanger Units
  • 7.6.Blood Reservoir
  • 7.7.Others

8.Global Heart-lung Machine Market, By Application 2021-2034 (USD Million)

  • 8.1.Coronary Artery Bypass Grafting (CABG)
  • 8.2.Heart Valve Surgeries
  • 8.3.Heart Transplant
  • 8.4.Lung Transplant
  • 8.5.Others

9.Global Heart-lung Machine Market, By End-User 2021-2034 (USD Million)

  • 9.1.Hospitals
  • 9.2.Cardiac Centers
  • 9.3.Others

10.Global Heart-lung Machine Market, 2021-2034 (USD Million)

  • 10.1.Global Heart-lung Machine Market Size and Market Share

11.Global Heart-lung Machine Market, By Region, 2021-2034 (USD Million)

  • 11.1.Asia-Pacific
    • 11.1.1.Australia
    • 11.1.2.China
    • 11.1.3.India
    • 11.1.4.Japan
    • 11.1.5.South Korea
    • 11.1.6.Rest of Asia-Pacific
  • 11.2.Europe
    • 11.2.1.France
    • 11.2.2.Germany
    • 11.2.3.Italy
    • 11.2.4.Spain
    • 11.2.5.United Kingdom
    • 11.2.6.Rest of Europe
  • 11.3.Middle East and Africa
    • 11.3.1.Kingdom of Saudi Arabia
    • 11.3.2.United Arab Emirates
    • 11.3.3.Qatar
    • 11.3.4.South Africa
    • 11.3.5.Egypt
    • 11.3.6.Morocco
    • 11.3.7.Nigeria
    • 11.3.8.Rest of Middle-East and Africa
  • 11.4.North America
    • 11.4.1.Canada
    • 11.4.2.Mexico
    • 11.4.3.United States
  • 11.5.Latin America
    • 11.5.1.Argentina
    • 11.5.2.Brazil
    • 11.5.3.Rest of Latin America

12.Company Profile

  • 12.1.Braile BiomA(C)dica
    • 12.1.1.Company details
    • 12.1.2.Financial outlook
    • 12.1.3.Interface summary
    • 12.1.4.Recent developments
  • 12.2.ELITE LIFECARE
    • 12.2.1.Company details
    • 12.2.2.Financial outlook
    • 12.2.3.Interface summary
    • 12.2.4.Recent developments
  • 12.3.Getinge
    • 12.3.1.Company details
    • 12.3.2.Financial outlook
    • 12.3.3.Interface summary
    • 12.3.4.Recent developments
  • 12.4.Hemovent GmbH
    • 12.4.1.Company details
    • 12.4.2.Financial outlook
    • 12.4.3.Interface summary
    • 12.4.4.Recent developments
  • 12.5.LivaNova, Inc
    • 12.5.1.Company details
    • 12.5.2.Financial outlook
    • 12.5.3.Interface summary
    • 12.5.4.Recent developments
  • 12.6.Medtronic
    • 12.6.1.Company details
    • 12.6.2.Financial outlook
    • 12.6.3.Interface summary
    • 12.6.4.Recent developments
  • 12.7.MERA (Senko Medical Instrument Mfg. Co., Ltd)
    • 12.7.1.Company details
    • 12.7.2.Financial outlook
    • 12.7.3.Interface summary
    • 12.7.4.Recent developments
  • 12.8.NIPRO
    • 12.8.1.Company details
    • 12.8.2.Financial outlook
    • 12.8.3.Interface summary
    • 12.8.4.Recent developments
  • 12.9.Technowood International Pte. Ltd
    • 12.9.1.Company details
    • 12.9.2.Financial outlook
    • 12.9.3.Interface summary
    • 12.9.4.Recent developments
    • 12.9.5.Others

13.Conclusion

14.List of Abbreviations

15.Reference Links